跳至主要内容
临床试验/IRCT201611241031N19
IRCT201611241031N19已完成1 期

Autologous bone marrow derived mononuclear cells (BMMNCs) subfacial transplantation in idiopathic lymphedema patients: clinical trial phase I

Royan Institute0 个研究点目标入组 6 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
10 years 至 35 years(—)
性别
All

入选标准

  • Age between 10-35 years; Idiopathic lower limb lymphedema; Grade less than III ; Resistant to conventional therapy; Informed consent.
  • Exclusion criteria:
  • Heart Failure (EF less than 45%); Renal failure (Cr more than 2) ; Hepatic failure (LFT more than 3 times) ; History of related surgery (lymph node dissection); History of Autoimmune disease; History of trauma or infection; History of pelvic malignancy or treatment for malignancy (Irradiation); Symptoms of sleep apnea; Previous bone marrow transplant; Morbid obesity or Lipedema (BMI = 40); Allergic disorders; Cytotoxic drugs; Drugs induced lymphedema; Congenital vascular malformation; Myxedema; Traveling to tropical countries or suspicion to filariasis; Dependency.

排除标准

  • 未提供

研究者

相似试验